» Articles » PMID: 35219803

Coronavirus Disease 2019 Scenarios for a Long-term Strategy Under Fundamental Uncertainty

Overview
Publisher Elsevier
Specialty Public Health
Date 2022 Feb 27
PMID 35219803
Authors
Affiliations
Soon will be listed here.
Abstract

Early on, scientists have pointed out that coronavirus disease 2019 is most likely here to stay, although its course and development are uncertain. This requires a long-term strategy of living with the virus. However, the urgency of new waves of infection and the emergence of new variants have invoked an approach of acute crisis management over and over, hindering the design of a structural approach for the long term. Exploratory scenarios can provide scientific strategic guidance to policy processes to be better prepared in this situation of fundamental uncertainty. We have therefore developed five scenarios, which describe the possible long-term development of the pandemic from an epidemiological, virological, and broader societal perspective. These scenarios are based on four driving forces that are both important and uncertain: immunity, vaccination, mutations, and human behavior. The scenarios are (1) return to normal, (2) flu+, (3) external threat, (4) continuous struggle, and (5) worst case. Working with scenarios is crucial for appropriate public communication and provides guidance for anticipating the various conceivable possibilities for the further course of the pandemic.

Citing Articles

Ultrasensitive and fast detection of SARS-CoV-2 using RT-LAMP without pH-dependent dye.

Alsaeed M, Alhamid G, Tombuloglu H, Kabanja J, Karagoz A, Tombuloglu G Funct Integr Genomics. 2024; 24(1):16.

PMID: 38242999 DOI: 10.1007/s10142-024-01297-z.


Impact of the COVID-19 pandemic on the conduct of non-COVID-19 clinical trials: protocol for a scoping review.

Shang W, Wei L, Liu Y, Pu H, Li X, Niu J BMJ Open. 2023; 13(10):e074128.

PMID: 37816556 PMC: 10565133. DOI: 10.1136/bmjopen-2023-074128.


Editors' Choice: August 2022.

Tovey D, Tugwell P J Clin Epidemiol. 2022; 148:A1-A2.

PMID: 36280379 PMC: 9595434. DOI: 10.1016/j.jclinepi.2022.08.011.


Health Beliefs and Socioeconomic Determinants of COVID-19 Booster Vaccine Acceptance: An Indonesian Cross-Sectional Study.

Wirawan G, Harjana N, Nugrahani N, Januraga P Vaccines (Basel). 2022; 10(5).

PMID: 35632482 PMC: 9146460. DOI: 10.3390/vaccines10050724.

References
1.
Kupferschmidt K . Scientists see a 'really, really tough winter' with Omicron. Science. 2021; 374(6574):1421-1422. DOI: 10.1126/science.acz9834. View

2.
Van Bavel J, Baicker K, Boggio P, Capraro V, Cichocka A, Cikara M . Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020; 4(5):460-471. DOI: 10.1038/s41562-020-0884-z. View

3.
Djulbegovic B, Guyatt G . Evidence-based medicine in times of crisis. J Clin Epidemiol. 2020; 126:164-166. PMC: 7348606. DOI: 10.1016/j.jclinepi.2020.07.002. View

4.
Knottnerus J, Tugwell P . Methodological challenges in studying the COVID-19 pandemic crisis. J Clin Epidemiol. 2020; 121:A5-A7. PMC: 7180157. DOI: 10.1016/j.jclinepi.2020.04.001. View

5.
Haddaway N, Akl E, Page M, Welch V, Keenan C, Lotfi T . Open synthesis and the coronavirus pandemic in 2020. J Clin Epidemiol. 2020; 126:184-191. PMC: 7328560. DOI: 10.1016/j.jclinepi.2020.06.032. View